Clinical Trials Browser

Carcinoma, Neuroendocrine × Irinotecan × Dermatologic × Clear all

NCT00004922 2013-06-19

Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors

Phase 2 Completed

DermatologicEndocrine

Neoplasms, Unknown Primary, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine